Radiation dose optimization in coronary angiography and percutaneous coronary intervention (PCI). II. Clinical evaluation.
In a previous part of this study, the fluoroscopy dose rate was reduced in a cardiac catheterization laboratory. The objectives of the present study were to evaluate the effects in a clinical population undergoing percutaneous coronary intervention (PCI) of the dose-reducing measures detailed previously. Kerma area-product (KAP) values were first recorded for 154 patients undergoing PCI. Then, the fluoroscopy KAP rate was reduced from 44 to 16 mGy cm(2)/s by increasing filtration and reducing the image intensifier dose request. After this optimization, KAP was recorded for another 138 PCI procedures. After adjustment for differing proportions of combined procedures (coronary angiography+PCI), the total KAP was reduced to 67% of the original value with a 95% confidence interval from 57 to 78%, statistically significant. The mean total KAP values were 93.6 Gy cm(2) before and 69.1 Gy cm(2) after optimization. The KAP for digital acquisition did not change significantly. It is possible to make a large dose reduction in PCI by reducing the fluoroscopy dose rate. This dose reduction is beneficial for both patients and staff.
Geijer
Håkan
H
Department of Radiology, Orebro University Hospital, 701 85 Orebro, Sweden. hakan.geijer@orebroll.se
Beckman
Karl-Wilhelm
KW
Andersson
Torbjörn
T
Persliden
Jan
J
D006328:Cardiac Catheterization; D017023:Coronary Angiography; D005260:Female; D005471:Fluoroscopy; D006801:Humans; D008297:Male; D008875:Middle Aged; D011829:Radiation Dosage; D015641:Radiography, Interventional